INTRODUCTION: The true incidence of chronic thromboembolic pulmonary hypertension
(CTPH) remains a matter of debate. Symptomatic CTPH is probably more common than …

Study objective To assess the incidence of chronic thromboembolic pulmonary hypertension
(CTPH) after the first episode of objectively confirmed pulmonary embolism (PE). Design …

INTRODUCTION AND OBJECTIVES: To assess the incidence of long-term symptomatic and
asymptomatic chronic thromboembolic pulmonary hypertension (CTPH) in a cohort of …

Background Chronic thromboembolic pulmonary hypertension (CTPH) is associated with
considerable morbidity and mortality. Its incidence after pulmonary embolism and …

Chronic thromboembolic pulmonary hypertension (CTEPH) has been estimated to occur in
0.1–0.5% of patients who survive a pulmonary embolism (PE), but more recent prospective …

INTRODUCTION: Although recurrent venous thromboembolism is a known risk factor for
chronic thromboembolic pulmonary hypertension (CTEPH), the prevalence of CTEPH after …

Background Early identification and treatment of chronic thromboembolic pulmonary
hypertension (CTEPH) are critical to prevent disease progression. We determined the …

Background The incidence and risk factors of chronic thromboembolic pulmonary
hypertension (CTEPH) in patients with acute pulmonary embolism (PE) have been well …

The incidence and prevalence of chronic thromboembolic pulmonary hypertension (CTEPH)
are yet to be accurately determined and may be significantly underestimated. Historically …

Aims To systematically assess late outcomes of acute pulmonary embolism (PE) and to
investigate the clinical implications of post-PE impairment (PPEI) fulfilling prospectively …